About
ProtonIntel develops CKM™, an investigational wearable platform with a minimally invasive sensor for continuous potassium monitoring to provide clinicians with real-time potassium data for managing cardio-kidney diseases such as heart failure and chronic kidney disease.
Explore ProtonIntel's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.